May 5, 2015: On February 3, 2015, the Food and Drug Administration approved a new drug called Ibrance for postmenopausal women with advanced breast cancer. FDA approves Ibrance for postmenopausal women with advanced breast cancer … Continue reading U.S. Food and Drug Administration Approves Ibrance | New Drug for Advanced Breast Cancer →